Simultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hamburg, Hannah ^a,b   Trossbach, Svenja V ^a   Bader, Verian ^a   Chwiesko, Caroline ^c   Kipar, Anja ^b   Sauvage, Magdalena ^c   Crum, William R ^d   Vernon, Anthony C ^d   Bidmon, Hans J ^a   Korth, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISC1 PROTEIN, HUMAN; NERVE PROTEIN; PARVALBUMIN;

ANIMAL; BIOMETRY; BIOSYNTHESIS; BRAIN; CYTOCHEMISTRY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; HUMAN; INTERNEURON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHIZOPHRENIA; SPRAGUE DAWLEY RAT; TRANSGENIC RAT;

ANIMALS; BIOMETRY; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; GENE EXPRESSION; HISTOCYTOCHEMISTRY; HUMANS; INTERNEURONS; MAGNETIC RESONANCE IMAGING; MALE; NERVE TISSUE PROTEINS; PARVALBUMINS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SCHIZOPHRENIA;

EID: 84991660679     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34946     Document Type: Article

References (75)

1. Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 35, 549-562 (2009).
2. Bakhshi, K. & Chance, S. A. The neuropathology of schizophrenia: A selective review of past studies and emerging themes in brain structure and cytoarchitecture. Neuroscience 303, 82-102 (2015).
3. Weinberger, D. R., Wagner, R. L. & Wyatt, R. J. Neuropathological studies of schizophrenia: a selective review. Schizophr Bull 9, 193-212 (1983).
4. Harrison, P. J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 (Pt 4), 593-624 (1999).
5. Prusiner, S. B. Shattuck lecture-neurodegenerative diseases and prions. N Engl J Med 344, 1516-1526 (2001).
6. Korth, C. Aggregated proteins in schizophrenia and other chronic mental diseases: DISC1opathies. Prion 6, 134-141 (2012).
7. van Erp, T. G. et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 21, 547-553 (2016).
8. Innocenti, G. M., Ansermet, F. & Parnas, J. Schizophrenia, neurodevelopment and corpus callosum. Mol Psychiatry 8, 261-274 (2003).
9. Wheeler, A. L. & Voineskos, A. N. A review of structural neuroimaging in schizophrenia: from connectivity to connectomics. Front Hum Neurosci 8, 653 (2014).
10. Woodruff, P. W., McManus, I. C. & David, A. S. Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry 58, 457-461 (1995).
11. Hulshoff Pol, H. E. et al. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage 21, 27-35 (2004).
12. Shergill, S. S. et al. A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry 164, 467-473 (2007).
13. Shenton, M. E., Dickey, C. C., Frumin, M. & McCarley, R. W. A review of MRI findings in schizophrenia. Schizophr Res 49, 1-52 (2001).
14. Emsley, R. et al. Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment. Schizophrenia Research 169, 89-94 (2015).
15. Chemerinski, E. et al. Larger putamen size in antipsychotic-naive individuals with schizotypal personality disorder. Schizophr Res 143, 158-164 (2013).
16. van Erp, T. G. et al. A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. Psychiatry Res 222, 10-16 (2014).
17. Haijma, S. V. et al. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull 39, 1129-1138 (2013).
18. Vernon, A. C. et al. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol Psychiatry 71, 855-863 (2012).
19. Vernon, A. C. et al. Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugslinking magnetic resonance imaging findings to cellular pathology. Biol Psychiatry 75, 982-990 (2014).
20. Lewis, D. A. Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia. Curr Opin Neurobiol 26, 22-26 (2014).
21. Volk, D. W. & Lewis, D. A. Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia. Schizophr Bull 40, 952-957 (2014).
22. Zilles, K. & Amunts, K. Individual variability is not noise. Trends Cogn Sci 17, 153-155 (2013).
23. Zilles, K. & Amunts, K. Centenary of Brodmanns map-conception and fate. Nat Rev Neurosci 11, 139-145 (2010).
24. Kamiya, A. et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7, 1167-1178 (2005).
25. Kamiya, A. et al. DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1. Hum Mol Genet 15, 3313-3323 (2006).
26. Lewis, D. A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25, 409-432 (2002).
27. St Clair, D. et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13-16 (1990).
28. Blackwood, D. H. et al. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 69, 428-433 (2001).
29. Sachs, N. A. et al. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry 10, 758-764 (2005).
30. Lipina, T. V. & Roder, J. C. Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: impact of mouse models. Neurosci Biobehav Rev 45, 271-294 (2014).
31. Niwa, M. et al. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 65, 480-489 (2010).
32. Steinecke, A., Gampe, C., Valkova, C., Kaether, C. & Bolz, J. Disrupted-in-Schizophrenia 1 (DISC1) is necessary for the correct migration of cortical interneurons. J Neurosci 32, 738-745 (2012).
33. Ishizuka, K. et al. DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. Nature 473, 92-96 (2011).
34. Singh, K. K. et al. Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development. Neuron 72, 545-558 (2011).
35. Steinecke, A., Gampe, C., Nitzsche, F. & Bolz, J. DISC1 knockdown impairs the tangential migration of cortical interneurons by affecting the actin cytoskeleton. Front Cell Neurosci 8, 190 (2014).
36. Shen, S. et al. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 28, 10893-10904 (2008).
37. Ayhan, Y. et al. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry 16, 293-306 (2011).
38. Hikida, T. et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 104, 14501-14506 (2007).
39. Pletnikov, M. V. et al. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 13, 173-186, 115 (2008).
40. Kvajo, M. et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci USA 105, 7076-7081 (2008).
41. Clapcote, S. J. et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54, 387-402 (2007).
42. Lee, F. H. et al. Disc1 point mutations in mice affect development of the cerebral cortex. J Neurosci 31, 3197-3206 (2011).
43. Juan, L. W. et al. Phenotypic characterization of C57BL/6J mice carrying the Disc1 gene from the 129S6/SvEv strain. Brain Struct Funct 219, 1417-1431 (2014).
44. Leliveld, S. R. et al. Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci 28, 3839-3845 (2008).
45. Trossbach, S. V. et al. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits. Mol Psychiatry (2016).
46. Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V. & Di Filippo, M. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci 17, 1022-1030 (2014).
47. Schilbach, L. et al. Transdiagnostic commonalities and differences in resting state functional connectivity of the default mode network in schizophrenia and major depression. Neuroimage Clin 10, 326-335 (2016).
48. Ludwig, S. et al. Spectral EEG abnormalities during vibrotactile encoding and quantitative working memory processing in schizophrenia. Neuroimage Clin 11, 578-587 (2016).
49. Hervig, M. E., Thomsen, M. S., Kallo, I. & Mikkelsen, J. D. Acute phencyclidine administration induces c-Fos-immunoreactivity in interneurons in cortical and subcortical regions. Neuroscience 334, 13-25 (2016).
50. Xu, Y., Zhuo, C., Qin, W., Zhu, J. & Yu, C. Altered Spontaneous Brain Activity in Schizophrenia: A Meta-Analysis and a Large- Sample Study. Biomed Res Int 2015, 204628 (2015).
51. Paxinos, G. The Rat Nervous System (Elsevier Science, 2014).
52. Saldeitis, K., Happel, M. F., Ohl, F. W., Scheich, H. & Budinger, E. Anatomy of the auditory thalamocortical system in the Mongolian gerbil: nuclear origins and cortical field-, layer-, and frequency-specificities. J Comp Neurol 522, 2397-2430 (2014).
53. Zilles, K. The Cortex of the Rat: A Stereotaxic Atlas (Springer Berlin Heidelberg, 2012).
54. Lerch, J. P. et al. Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse. Front Neuroinform 6, 6 (2012).
55. van Eede, M. C., Scholz, J., Chakravarty, M. M., Henkelman, R. M. & Lerch, J. P. Mapping registration sensitivity in MR mouse brain images. Neuroimage 82, 226-236 (2013).
56. Gundersen, H. J. et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96, 379-394 (1988).
57. Michel, R. P. & Cruz-Orive, L. M. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc 150, 117-136 (1988).
58. Brandon, N. J. et al. Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci 29, 12768-12775 (2009).
59. Brandon, N. J. & Sawa, A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 12, 707-722 (2011).
60. Korth, C. DISCopathies: brain disorders related to DISC1 dysfunction. Rev Neurosci 20, 321-330 (2009).
61. Crittenden, J. R. & Graybiel, A. M. Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat 5, 59 (2011).
62. Tamamaki, N. et al. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467, 60-79 (2003).
63. Benes, F. M. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res 31, 257-275 (1997).
64. Lewis, D. A., Pierri, J. N., Volk, D. W., Melchitzky, D. S. & Woo, T. U. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 46, 616-626 (1999).
65. Le Moine, C. & Gaspar, P. Subpopulations of cortical GABAergic interneurons differ by their expression of D1 and D2 dopamine receptor subtypes. Brain Res Mol Brain Res 58, 231-236 (1998).
66. Hattori, T. et al. DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One 9, e88506 (2014).
67. Del Re, E. C. et al. Enlarged lateral ventricles inversely correlate with reduced corpus callosum central volume in first episode schizophrenia: association with functional measures. Brain Imaging Behav (2015).
68. Vernon, A. C., Crum, W. R., Johansson, S. M. & Modo, M. Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinsons disease. PLoS One 6, e17269 (2011).
69. Smith, E. J. et al. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells 30, 785-796 (2012).
70. Crum, W. R. et al. A comparison of automated anatomical-behavioural mapping methods in a rodent model of stroke. J Neurosci Methods 218, 170-183 (2013).
71. Crum, W. R., Modo, M., Vernon, A. C., Barker, G. J. & Williams, S. C. Registration of challenging pre-clinical brain images. J Neurosci Methods 216, 62-77 (2013).
72. Crum, W. R., Tanner, C. & Hawkes, D. J. Anisotropic multi-scale fluid registration: evaluation in magnetic resonance breast imaging. Phys Med Biol 50, 5153-5174 (2005).
73. Fox, N. C. et al. Imaging of onset and progression of Alzheimers disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358, 201-205 (2001).
74. Genovese, C. R., Lazar, N. A. & Nichols, T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15, 870-878 (2002).
75. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition (Elsevier Science, 2006).